Meeder Advisory Services’s GSK GSK Stock Holding History

Meeder Advisory Services’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$244K	Sell	4,649 -33	-0.7%	-$1.75K	0.01%	633
2026 Q1	$258K	Sell	4,682 -849	-15%	-$46K	0.01%	570
2025 Q4	$271K	Buy	5,531 +45	+0.8%	+$2.1K	0.01%	560
2025 Q3	$237K	Buy	+5,486	New	+$214K	0.01%	552

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Meeder Advisory Services's GSK Position: Q2 2026 in Review

Meeder Advisory Services reduced its GSK (GSK) stake by 0.7% in Q2 2026, selling an estimated $1.75K and leaving 4,649 shares worth $244K. The position accounts for 0.01% of the portfolio, ranked #633.

Meeder Advisory Services first reported a position in GSK in Q3 2025 and has held it in 4 quarters since. The position peaked at $271K in Q4 2025. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Meeder Advisory Services held 4,649 shares of GSK worth $244K as of Q2 2026.
Meeder Advisory Services sold 33 GSK shares in Q2 2026, an estimated $1.75K.
GSK made up 0.01% of Meeder Advisory Services's portfolio in Q2 2026, its #633 holding.
Meeder Advisory Services first reported a position in GSK in Q3 2025 and has held it in 4 quarters since.
Meeder Advisory Services's GSK position peaked at $271K in Q4 2025.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Meeder Advisory Services's 13F filing for Q2 2026, filed 7 Aug 2026.